Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 114
Selected: 0
NCT IDTitle
NCT07840001Neoadjuvant Belzutifan Plus Pembrolizumab in High-Risk, Locally Advanced Clear Cell Renal Cell Carcinoma
NCT00193934Magnetic Resonance Imaging (MRI) Staging of Cervix Cancer
NCT00431990A Phase I/II Trial of Romidepsin (Depsipeptide) and Bortezomib in Patients With Relapsed Myeloma
NCT03851146A Study of Anti-Lewis Y Chimeric Antigen Receptor-T Cells (LeY-CAR-T) in Patients With Solid Tumours
NCT05666700CAR-T Cell Therapy in RelApsed/Refractory Myeloma With ExtrameduLlary Disease - an in Vivo Imaging and Molecular Monitoring Study
NCT03658447PRINCE (PSMA-lutetium Radionuclide Therapy and ImmuNotherapy in Prostate CancEr)
NCT03874884177Lu-PSMA-617 Therapy and Olaparib in Patients With Metastatic Castration Resistant Prostate Cancer
NCT04316013Volatile Anaesthesia and Perioperative Outcomes Related to Cancer: the VAPOR-C Trial
NCT02385214MelmarT Melanoma Margins Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma
NCT00234169A Study of Peripheral Blood Progenitor Cells Mobilisation (PBPC) With VTP195183 Plus Granulocyte-Colony Stimulating Factor (G-CSF) Compared to Mobilisation With G-CSF Alone
NCT06631872Implementing Surgery School Prehabilitation Using Telehealth
NCT01755650Phase 0 of 18F FPM Using PET/CT in Patients With a Variety of Malignancies
NCT01742793An Open Label, International, Multi-centre, Phase I/IIa Study of Lenalidomide (Revlimid) and Romidepsin (Istodax) for Relapsed /Refractory Hodgkin Lymphoma, Mature T-cell Lymphoma and Multiple Myeloma. (RId Study)
NCT04918810Biomarker-driven Intermittent Docetaxel in Metastatic Castration-resistant Prostate Cancer
NCT06510699Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial
NCT06127654Ventilation Imaging to Improve the Quality of Life for Patients With Lung Cancer Treated With Radiation Therapy
NCT05182931A Prospective, Multi-Centre Trial of TKI Redifferentiation Therapy in Patients With RAIR Thyroid Cancer (I-FIRST Study)
NCT03034577Deep Neuromuscular Block for Laparoscopic Surgery
NCT05169177Radio-opaque Contrast Agents for Liver Cancer Targeting With KIM During Radiation Therapy
NCT00351598Lung Tumour Volume Database
NCT05983159A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations
NCT02855203Stereotactic Radiotherapy and Anti-PD1 Antibody (Pembrolizumab) for Oligometastatic Renal Tumours
NCT05053854PARP Inhibitor With 177Lu-DOTA-Octreotate PRRT in Patients With Neuroendocrine Tumours
NCT00335348Bortezomib and Dexamethasone as Treatment and Maintenance for Multiple Myeloma Relapse
NCT01493206A Prospective Single Arm Study of Intraoperative Radiotherapy for Locally Advanced or Recurrent Rectal Cancer
NCT01658241Panobinostat Biological Correlates Study
NCT04319783Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA
NCT03363867BEACON - ABC in Recurrent Platinum Resistant HGSOC
NCT04914741A Multicentre, Parallel Arm, Open-label Trial of Frontline R-CHOP/Pola-RCHP and Glofitamab in Younger, Higher Risk Patients With Diffuse Large B Cell Lymphoma (DLBCL)
NCT07090369Phase Ib Trial of 177Lu-PSMA-I&T Therapy in Combination With Olaparib and Pembrolizumab in Patients With Metastatic Castration Resistant Prostate Cancer
NCT00581880Measuring Hope and Hopelessness in Cancer
NCT02999893A Study of APR-246 in Oesophageal Cancer
NCT00422864A Single Arm Trial of Oxaliplatin and 5FU With Concurrent Radiation in Patients With Metastatic Rectal Cancer
NCT07434180Phase II Trial of Lu-177 FAP-2286 in Patients With Carcinoma of Unknown Primary
NCT00206609The Role of Oxygen in the Management of Dyspnoea in Advanced Cancer
NCT05263700FAPI-CUP- Evaluating FAPI as a Novel Radiopharmaceutical for Cancer of Unknown Primary
NCT02468687NMP in Relapsed / Refractory Myeloma
NCT05222087PRIME_LUNG: Primary Radiotherapy In MEtastatic Lung Cancer - A Pilot Study
NCT06279260National Robotics-Assisted Radical Prostatectomy Database
NCT05560659Lu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative Radiotherapy
NCT01488565A Single Arm Pilot Study of Azacitidine in Myelodysplastic Syndromes (MDS) / Acute Myeloid Leukaemia (AML), With Eltrombopag Support for Thrombocytopenia
NCT05878288Deep sequencIng in Cutaneous Squamous CEll caRciNomas
NCT05570227Metabolic Phenotypes in Melanoma
NCT00098995Tirapazamine, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer
NCT04739670Evaluating the Efficacy and Safety of Bevacizumab, Carboplatin, Gemcitabine and Atezolizumab in Breast Cancer
NCT05425862Pidnarulex and Talazoparib in Patients With Metastatic Castration Resistant Prostate Cancer
NCT04074460Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility Study
NCT01716364Safety Study of Anti LewisY Chimeric Antigen Receptor in Myeloma, Acute Myeloid Leukemia or Myelodysplastic Syndrome
NCT07527819Evaluating Ovarian Toxicity Outcomes Following Immunotherapy in Patients With Triple-Negative Breast Cancer (TNBC)
NCT03161756Evaluation of Denosumab in Combination With Immune Checkpoint Inhibitors in Patients With Unresectable or Metastatic Melanoma